Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Biogen Idec and Isis Pharmaceuticals enter global antisense drug collaboration

Dec. 11, 2012

University of Texas MD Anderson and GSK to collaborate on therapeutic antibodies against cancer

Dec. 11, 2012

Cytomedix signs agreement with NIH for phase II study of Bright Cells

Dec. 10, 2012

Protalix and Pfizer sign new agreement for clinical development of Elelyso

Dec. 7, 2012

Gentium to begin phase I development of defibrotide in Japan

Dec. 7, 2012

Vical licenses adjuvant to Cyvax for malaria vaccines

Dec. 7, 2012

Cerecor signs option with Johns Hopkins for DAAO inhibitor platform

Dec. 7, 2012

uniQure and Benitec Biopharma enter cross-licensing agreement

Dec. 5, 2012

PharmaEssentia acquires certain rights to KX-01 in Asia

Dec. 4, 2012

Optimer Pharmaceuticals and AstraZeneca collaborate on fidaxomicin

Dec. 4, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...